Test Price
2,800 AED✅ Home Collection Available
NECAP1 Gene Early Infantile Epileptic Encephalopathy Type 21 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NECAP1 للاعتلال الدماغي الصرعي الطفولي المبكّر من النوع 21 بتقنية التسلسل الجيني في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي 2026
Clinical Excellence & UAE Compliance: Our ISO 9001:2015 certified laboratory delivers 99.9% diagnostic sensitivity for NECAP1 variant detection via advanced NGS, ensuring accurate identification of pathogenic mutations linked to EIEE21.
Premium Home Collection: VIP mobile phlebotomy service across all Emirates (8 AM–11 PM) with ISO-certified cold-chain transport, preserving DNA integrity from collection to sequencing.
Post-Test Guidance: Complimentary telephonic genetic counseling session to interpret results and discuss next steps, aligned with Federal Decree-Law No. 41 of 2024 (Art. 87) and CDS Law 2026 for minors.
Insurance Made Easy: Direct billing verification via WhatsApp at +971 54 548 8731—we confirm coverage before the draw.
دقة تشخيصية عالية بنسبة 99.9% مع خدمة سحب منزلي متميزة واستشارة وراثية هاتفية بعد الفحص، متوافقة مع القوانين الاتحادية لدولة الإمارات.
Test Overview & Comparative Edge
The NECAP1 Gene NGS Test sequences the entire coding region of NECAP1 to diagnose early infantile epileptic encephalopathy type 21 (EIEE21), an autosomal recessive disorder causing severe infantile-onset seizures and developmental regression. Our accredited assay achieves >99.9% analytical sensitivity and specificity, exceeding standard single-gene tests by covering all coding exons with a turnaround time of just 3–4 weeks.
| Feature | Our NECAP1 NGS Test | General Multi-Gene Panel |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full exon coverage | May use limited Sanger sequencing or targeted gene subsets |
| Turnaround Time | 3–4 Weeks (urgent options available) | 4–8 Weeks |
| Variant Detection | Full gene analysis including deep intronic regions | Often limited to hotspot exons |
| Clinical Support | Post-test genetic counseling included | Rarely included |
Physician Insight & Safety Protocol
"As a neurologist with two decades of experience, I understand the profound anxiety families face when developmental milestones are interrupted by seizures. This test can pinpoint the genetic cause, but results must always be correlated with the child’s clinical picture and EEG findings. A negative result does not rule out non-genetic epileptic encephalopathies; continue working with your pediatric neurologist."
— Dr. Prabhakar Reddy, DHA License 61713011
⚠️ Medication Warning: Do not discontinue any antiepileptic medication without consulting your treating physician. Genetic testing complements, not replaces, ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals with acute febrile illness or hemodynamic instability; specimens from patients on high-dose anticoagulants (risk of excessive bleeding) require physician clearance.
- Exclusion: Refusal or inability of parent/guardian to provide informed consent for a minor.
- ER Red Flags: New-onset prolonged seizure (>5 minutes), status epilepticus, or sudden deterioration in consciousness — seek emergency care immediately, not a scheduled lab test.
- If a sibling shows similar symptoms, consult a clinical geneticist urgently before sample collection.
Patient FAQ & Clinical Guidance
1. What is the NECAP1 gene and why is this test needed?
The NECAP1 gene encodes a protein essential for neuronal vesicle recycling; pathogenic mutations cause early infantile epileptic encephalopathy type 21, characterized by refractory seizures and neurodevelopmental stagnation. This identifies disease-causing variants to guide precise treatment, inform family planning, and connect you with ongoing research studies.
يوفر تحليل جين NECAP1 كشفاً دقيقاً للطفرات المسببة للاعتلال الدماغي الصرعي الطفولي المبكّر، مما يتيح تخصيص العلاج والاستشارة الوراثية للعائلة.
2. How is the sample collected, and is it painful for my infant?
Our pediatric-trained phlebotomists use a gentle heel-stick or venous draw with a topical anesthetic, and a single drop on an FTA card is sufficient; the procedure is swift and comparable to a routine vaccination.
تتم عملية سحب العينة بطريقة لطيفة من كعب القدم أو الوريد باستخدام مخدّر موضعي، ويكفي قطرة دم واحدة على بطاقة FTA، فلا داعي للقلق.
3. Will my health insurance cover the 2800 AED cost?
Most UAE comprehensive health plans include genetic testing for medically indicated neurological conditions; simply send your insurance card via WhatsApp to +971 54 548 8731 and we will confirm pre-authorization within 1 hour, with no upfront payment if approved.
تغطي معظم خطط التأمين في الإمارات الاختبارات الجينية للحالات العصبية المبرّرة طبياً؛ أرسل بطاقة التأمين عبر واتساب للتحقق الفوري من الموافقة المسبقة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians